Treatment adherence and long-term outcomes

被引:71
|
作者
Kane, John M. [1 ]
机构
[1] N Shore Long Isl Jewish Hlth Syst, Behav Hlth Serv, Great Neck, NY 11021 USA
[2] Zucker Hillside Hosp, Dept Psychiat, Glen Oaks, NY USA
[3] Albert Einstein Coll Med, New York, NY USA
关键词
RANDOMIZED CONTROLLED-TRIAL; COMPLIANCE THERAPY; SCHIZOAFFECTIVE DISORDER; MEDICATION ADHERENCE; 1ST-EPISODE SCHIZOPHRENIA; 1ST EPISODE; RELAPSE; RISK; NONADHERENCE; PREDICTORS;
D O I
10.1017/S1092852900026304
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The successful management of schizophrenia is an enormous public health issue. Although antipsychotic medications can be very helpful in reducing rates of relapse and rehospitalization, nonadherence to medication is a frequent cause of exacerbations in psychopathology, psychotic relapse, and rehospitalization. Relapses can have devastating consequences in a variety of clinical and functional domains. Nonadherence can result from a variety of factors that vary from patient to patient and vary over time in individual patients. A number of strategies have been developed to assess and facilitate adherence. The first critical step is clinician awareness of the scope of the problem and consideration of appropriate strategies to address it.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [1] Treatment adherence and long-term outcomes of bipolar disorder
    Thase, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S589 - S590
  • [2] Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care
    Ascher-Svanum, H
    Faries, DE
    Zhu, BJ
    Ernst, FR
    Swartz, MS
    Swanson, JW
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (03) : 453 - 460
  • [3] Long-term adherence to statin treatment in diabetes
    Donnelly, L. A.
    Doney, A. S. F.
    Morris, A. D.
    Palmer, C. N. A.
    Donnan, P. T.
    DIABETIC MEDICINE, 2008, 25 (07) : 850 - 855
  • [4] Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes
    Bansilal, Sameer
    Maria Castellano, Jose
    Garrido, Ester
    Wei, Henry G.
    Freeman, Allison
    Spettell, Claire
    Garcia-Alonso, Fernando
    Lizano, Irene
    Arnold, Renee J. G.
    Rajda, Jay
    Steinberg, Gregory
    Fuster, Valentin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (08) : 789 - 801
  • [5] Long-term outcomes of short-term and long-term psychosomatic inpatient treatment and their predictors
    Schaefer, Anke
    Gieler, Uwe
    Kurth, Regina
    Brosig, Burkhard
    Leweke, Frank
    Milch, Wolfgang E.
    Reimer, Christian
    Beutel, Manfred E.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2008, 65 (04) : 329 - 336
  • [6] Third witness - long-term treatment outcomes
    Wunderink, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S675 - S675
  • [7] Long-term outcomes of treatment of hyperthyroidism in Ireland
    A. C. Leary
    G. Grealy
    T. M. Higgins
    N. Buckley
    D. G. Barry
    D. Murphy
    J. B. Ferriss
    Irish Journal of Medical Science, 1999, 168 : 47 - 52
  • [8] DTC Treatment and Long-Term Cardiac Outcomes
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 18N - 18N
  • [9] LONG-TERM OUTCOMES OF MODERN TREATMENT: MORTALITY
    Askling, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 3 - 3
  • [10] Long-term treatment outcomes in Gaucher disease
    Charrow, Joel
    Scott, C. Ronald
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 : S19 - S24